Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2014Molecular Medicine ReportsOpen Access

Direct thrombin inhibitors: Patents 2002–2012 (Review)

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYi KongChina Pharmaceutical UniversityHCHao ChenBGI Group (China)YWYongqing WangUniversity of Toledo Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kong et al. (2014) studied this question.

synapsesocial.com/papers/6a600e1cc2662a747aa62e2bhttps://doi.org/10.3892/mmr.2014.2025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pegaptanib sodium for the treatment of neovascular age-related macular degeneration2005 · 59 citations
  2. 2Recombinant Hirudin in Clinical Practice2001 · 136 citations